← FDA Drug Approvals (Drugs@FDA)

ETOPOSIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 1998-09-30

Drug application

FDA Application #

ANDA074983

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETOPOSIDE

Generic name

ETOPOSIDE

Active ingredients

ETOPOSIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

1998-09-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown